These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 404249)

  • 1. Antitumor activity of a Brucella abortus preparation.
    Keleti G; Feingold DS; Youngner JS
    Infect Immun; 1977 Mar; 15(3):846-9. PubMed ID: 404249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of an ether-extracted nonviable preparation of Brucella abortus.
    Youngner JS; Keleti G; Feingold DS
    Infect Immun; 1974 Dec; 10(6):1202-6. PubMed ID: 4373393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the activity of a Brucella abortus preparation, Bru-Pel.
    Youngner JS; Feingold DS; Keleti G
    Cancer Treat Rep; 1978 Nov; 62(11):1915-8. PubMed ID: 728911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel.
    Schultz RM; Chirigos MA; Pavlidis NA; Youngner JS
    Cancer Treat Rep; 1978 Nov; 62(11):1937-41. PubMed ID: 103619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation in treatment of mice with tumors.
    Fisher B; Linta J; Hanlon J; Saffer E
    J Natl Cancer Inst; 1978 Feb; 60(2):391-9. PubMed ID: 413929
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.
    Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
    Infect Immun; 1979 Jan; 23(1):19-26. PubMed ID: 106004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation with killed Propionibacterium acnes in guinea pigs simultaneously vaccinated with Brucella abortus strain 19.
    Panangala VS; Haynes TB; Schultz RD; Mitra A
    Vet Immunol Immunopathol; 1986 Sep; 13(1-2):71-84. PubMed ID: 3094237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced resistance of Corynebacterium parvum-treated mice to infection by bacteria.
    Adlam C; Broughton ES; Scott MT
    J Med Microbiol; 1972 Feb; 5(1):Pvii. PubMed ID: 4336739
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of Corynebacterium parvum and Corynebacterium liquefaciens on antitumor activity against sarcoma-180.
    Ideda H; Yamagata S; Toge T; Hattori T
    Gan; 1977 Apr; 68(2):233-5. PubMed ID: 892298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of natural killer cell activity in mice by Bru-Pel.
    Yabu K; Youngner JS; Feingold DS; Keleti G; Gorelik E
    J Immunother (1991); 1991 Oct; 10(5):307-12. PubMed ID: 1790138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of three species of Propionibacteria (P. granulosum, P. acnes, P. avidum) on experimental tumor systems in mice.
    Roszkowski W; Kobus M; Luczak M; Ko HL; Szmigielski S; Laskowska B; Pulverer G; Jeljaszewicz J
    Zentralbl Bakteriol A; 1980 Mar; 246(3):405-14. PubMed ID: 6252722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of Brucella abortus preparations; separation of active components.
    Feingold DS; Keleti G; Youngner JS
    Infect Immun; 1976 Mar; 13(3):763-7. PubMed ID: 818014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B; Gebhardt M
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortus.
    Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
    Cancer Treat Rep; 1978 Nov; 62(11):1931-5. PubMed ID: 282007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of antigenic competition by immunostimulants].
    Martin A; Toujas L; Dazord L; Guelfi J
    C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(21):1645-8. PubMed ID: 56240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal conditions for antitumor activity of C. parvum against the ascites form of sarcoma 180.
    Megirian R; Astry CL; Spoor RP; Loose LD
    J Immunopharmacol; 1980; 2(1):99-112. PubMed ID: 7452006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of arginine butyrate in conjunction with Corynebacterium parvum and interferon.
    Chany C; Cerutti I
    Int J Cancer; 1982 Oct; 30(4):489-93. PubMed ID: 6183228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of cell walls from Brucella abortus.
    Collet B; Martin A; Le Garrec Y; Dubray G; Toujas L
    J Natl Cancer Inst; 1983 Sep; 71(3):529-34. PubMed ID: 6411957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymhocyte stimulatory effect of an ether-extracted preparation of Brucella abortus.
    Stylos WA; Chirigos MA; Lengel CR
    Cancer Treat Rep; 1978 Nov; 62(11):1949-54. PubMed ID: 310345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of arginine butyrate on the development of Crocker 180/TG tumor in Swiss mice].
    Chany C; Cerutti I
    C R Seances Acad Sci III; 1981 Oct; 293(7):367-9. PubMed ID: 6797689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.